Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunology. Targeting the tolls.

× No keyword cloud information.

9 in total

1. Albumin-based microbubbles bind up-regulated scavenger receptors following vascular injury.

Authors: Daniel R Anderson; Michael J Duryee; Rajeev K Anchan; Robert P Garvin; Michael D Johnston; Thomas R Porter; Geoffrey M Thiele; Lynell W Klassen
Journal: J Biol Chem Date: 2010-10-21 Impact factor: 5.157

2. Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN).

Authors: A Ruzsa; M Sen; M Evans; L W Lee; K Hideghety; S Rottey; P Klimak; P Holeckova; J Fayette; T Csoszi; J Erfan; U Forssmann; T Goddemeier; A Bexon; C Nutting
Journal: Invest New Drugs Date: 2014-06-04 Impact factor: 3.850

3. Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques.

Authors: M Anthony Moody; Sampa Santra; Nathan A Vandergrift; Laura L Sutherland; Thaddeus C Gurley; Mark S Drinker; Ashley A Allen; Shi-Mao Xia; R Ryan Meyerhoff; Robert Parks; Krissey E Lloyd; David Easterhoff; S Munir Alam; Hua-Xin Liao; Brandy M Ward; Guido Ferrari; David C Montefiori; Georgia D Tomaras; Robert A Seder; Norman L Letvin; Barton F Haynes
Journal: J Virol Date: 2014-01-03 Impact factor: 5.103

Review 4. Thrombosis in COVID-19 infection: Role of platelet activation-mediated immunity.

Authors: Mahin Behzadi Fard; Samaneh Behzadi Fard; Shahin Ramazi; Amir Atashi; Zahra Eslamifar
Journal: Thromb J Date: 2021-08-23

Review 5. Innate immunity and toll-like receptor antagonists: a potential role in the treatment of cardiovascular diseases.

Authors: Elaine Lin; Jane E Freedman; Lea M Beaulieu
Journal: Cardiovasc Ther Date: 2009 Impact factor: 3.023

6. Immunization with a Toll-like receptor 7 and/or 8 agonist vaccine adjuvant increases protective immunity against Leishmania major in BALB/c mice.

Authors: Wen-Wei Zhang; Greg Matlashewski
Journal: Infect Immun Date: 2008-05-12 Impact factor: 3.441

7. Innate immunity and chronic rhinosinusitis: What we have learned from animal models.

Authors: Nyall R London; Andrew P Lane
Journal: Laryngoscope Investig Otolaryngol Date: 2016-06-10

8. Immunogenicity and protection effects of cationic liposome containing imiquimod adjuvant on leishmaniasis in BALB/c mice.

Authors: Ahmad Mehravaran; Maryam Rezaei Nasab; Hadi Mirahmadi; Iraj Sharifi; Ebrahim Alijani; Amin Reza Nikpoor; Javad Akhtari; Mansure Hojatizade
Journal: Iran J Basic Med Sci Date: 2019-08 Impact factor: 2.699

9. Genomics in cardiovascular diseases: analysis of the importance of the toll-like receptor signaling pathway.

Authors: J Bustamante; E Tamayo; J Herreros
Journal: Int J Gen Med Date: 2012-10-25

9 in total